Format
Sort by
Items per page

Send to

Choose Destination

Selected items

Items: 1 to 20 of 21

1.

Saudi Oncology Society clinical management guidelines for renal cell carcinoma.

Bazarbashi S, Al Othman K, Al Otaibi M, Abusamra A, Rabah D, Aljubran A, Murshid E, Al Oraifi I, El-Naghi M, Bahader Y, Soudy H, Rehman A.

Urol Ann. 2011 Mar;3 Suppl:S3-5. doi: 10.4103/0974-7796.78548.

2.

Saudi Oncology Society clinical management guidelines for testicular germ cell tumors.

Al Otaibi M, El-Naghi M, Balaraj K, Bazarbashi S, Rabah D, Al Othman K, Al Saeed E, Al Ghamdi A, Aljubran A, Murshid E, Al Oraifi I, Al Kushi H.

Urol Ann. 2011 Mar;3 Suppl:S17-20. doi: 10.4103/0974-7796.78551. Erratum in: Urol Ann. 2011 May-Aug; 3(2):61. Rabbah, Dany [corrected to Rabah, Danny].

3.
4.

Adjuvant chemotherapy for rectal cancer: time to change the guidelines.

Bazarbashi S, Aljubran A, Alzahrani A.

Future Oncol. 2016;12(8):1009-13. doi: 10.2217/fon-2015-0042. Epub 2016 Feb 10. Review. No abstract available.

PMID:
26863297
5.

Co-administration of intravesical bacillus Calmette-Guérin and interferon α-2B as first line in treating superficial transitional cell carcinoma of the urinary bladder.

Bazarbashi S, Soudy H, Abdelsalam M, Al-Jubran A, Akhtar S, Memon M, Aslam M, Kattan S, Shoukri M.

BJU Int. 2011 Oct;108(7):1115-8. doi: 10.1111/j.1464-410X.2010.10040.x. Epub 2011 Feb 18.

6.

Pre-operative chemoradiotherapy using capecitabine and cetuximab followed by definitive surgery in patients with operable rectal cancer.

Bazarbashi S, Omar A, Aljubran A, Alzahrani A, Alsanea N, Abduljabbar A, Alhomoud S, Ashari L, Balaraj K, Soudy H, Neimatallah M, Fagih M.

Hematol Oncol Stem Cell Ther. 2016 Dec;9(4):147-153. doi: 10.1016/j.hemonc.2016.08.004. Epub 2016 Sep 2.

7.

Phase I/II trial of capecitabine, oxaliplatin, and irinotecan in combination with bevacizumab in first line treatment of metastatic colorectal cancer.

Bazarbashi S, Aljubran A, Alzahrani A, Mohieldin A, Soudy H, Shoukri M.

Cancer Med. 2015 Oct;4(10):1505-13. doi: 10.1002/cam4.497. Epub 2015 Jul 24.

8.

Saudi Oncology Society clinical management guideline series. Pancreatic cancer 2014.

Rahal MM, Bazarbashi SN, Kandil MS, Al-Shehri AS, Alzahrani AM, Aljubran AH, Zekri JE, Al Olayan AA, Alsharm AA, Kabbani MA, Fagih MA; Saudi Oncology Society.

Saudi Med J. 2014 Dec;35(12):1534-7. No abstract available.

9.

Saudi Oncology Society clinical management guideline series. Colorectal cancer 2014.

Bazarbashi SN, Alzahrani AM, Rahal MM, Al-Shehri AS, Aljubran AH, Alsanea NA, Al-Obeed OA, Kandil MS, Zekri JE, Al Olayan AA, Alsharm AA, Balaraj KS, Fagih MA; Saudi Oncology Society.

Saudi Med J. 2014 Dec;35(12):1538-44. No abstract available.

10.

Saudi Oncology Society clinical management guideline series. Anal canal cancer 2014.

Bazarbashi SN, Alzahrani AM, Rahal MM, Al-Shehri AS, Aljubran AH, Alsanea NA, Al-Obeed OA, Kandil MS, Zekri JE, Al Olayan AA, Alsharm AA, Balaraj KS; Saudi Oncology Society.

Saudi Med J. 2014 Dec;35(12):1527-8. No abstract available.

11.

Saudi Oncology Society clinical management guideline series. Esophageal cancer 2014.

Alzahrani AM, Bazarbashi SN, Rahal MM, Al-Shehri AS, Aljubran AH, Kandil MS, Zekri JE, Al Olayan AA, Alsharm AA, Yamani NM, Alomary IS, Fagih MA; Saudi Oncology Society.

Saudi Med J. 2014 Dec;35(12):1545-9. No abstract available.

12.

Saudi Oncology Society clinical management guideline series. Gastric cancer 2014.

Kandil MS, Bazarbashi SN, Rahal MM, Al-Shehri AS, Alzahrani AM, Aljubran AH, Zekri JE, Al Olayan AA, Alsharm AA, Yamani NM, Alomary IS, Fagih MA; Saudi Oncology Society.

Saudi Med J. 2014 Dec;35(12):1529-33. No abstract available.

13.

Metastatic synovial sarcoma of the foot to the throat.

Aljubran A, Tulba A, Akhtar S.

Am J Clin Oncol. 2008 Apr;31(2):205-6. doi: 10.1097/01.coc.0000203757.52100.fa. No abstract available.

PMID:
18391608
14.

Improved compliance with adjuvant vinorelbine and cisplatin in non-small cell lung cancer.

Aljubran A, Leighl N, Pintilie M, Burkes R.

Hematol Oncol Stem Cell Ther. 2009;2(1):265-71.

15.

The attitude towards disclosure of bad news to cancer patients in Saudi Arabia.

Aljubran AH.

Ann Saudi Med. 2010 Mar-Apr;30(2):141-4. doi: 10.4103/0256-4947.60520. Review.

16.

Osteosarcoma in adolescents and adults: survival analysis with and without lung metastases.

Aljubran AH, Griffin A, Pintilie M, Blackstein M.

Ann Oncol. 2009 Jun;20(6):1136-41. doi: 10.1093/annonc/mdn731. Epub 2009 Jan 19.

PMID:
19153114
17.

Carotid and brachiocephalic arteries stenosis with long term use of sorafenib.

Maraiki F, Aljubran A.

Hematol Oncol Stem Cell Ther. 2014 Mar;7(1):53-5. doi: 10.1016/j.hemonc.2013.06.005. Epub 2013 Jul 24.

18.

Immature mediastinal teratoma with unusual histopathology: A case report of multi-lineage, somatic-type malignant transformation and a review of the literature.

Mustafa OM, Mohammed SF, Aljubran A, Saleh WN.

Medicine (Baltimore). 2016 Jun;95(26):e3378. doi: 10.1097/MD.0000000000003378. Review.

19.

Knowledge, Perception, and Attitudes of Cancer Patients Towards Cancer and Cancer Care: Local Perspective from Saudi Arabia.

Mohieldin A, Eldali A, Aljubran A.

J Cancer Educ. 2017 Jun;32(2):314-319. doi: 10.1007/s13187-015-0973-2.

PMID:
26803820
20.

Papular-purpuric "gloves and socks" syndrome in a mother and daughter.

Alfadley A, Aljubran A, Hainau B, Alhokail A.

J Am Acad Dermatol. 2003 Jun;48(6):941-4.

PMID:
12789189

Supplemental Content

Support Center